Cargando…
Evidence of a synthetic lethality interaction between SETDB1 histone methyltransferase and CHD4 chromatin remodeling protein in a triple negative breast cancer cell line
During the tumorigenic process, cancer cells may become overly dependent on the activity of backup cellular pathways for their survival, representing vulnerabilities that could be exploited as therapeutic targets. Certain molecular vulnerabilities manifest as a synthetic lethality relationship, and...
Autores principales: | Moraes-Almeida, M.S., Sogayar, M.C., Demasi, M.A.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644962/ https://www.ncbi.nlm.nih.gov/pubmed/37970920 http://dx.doi.org/10.1590/1414-431X2023e12854 |
Ejemplares similares
-
The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma
por: Ceol, Craig J., et al.
Publicado: (2011) -
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer
por: Nishikawaji, Taketo, et al.
Publicado: (2016) -
Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis
por: Rodriguez-Paredes, M, et al.
Publicado: (2014) -
Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response
por: Zhao, Zhipeng, et al.
Publicado: (2022) -
Chromatin remodelers Isw1 and Chd1 maintain chromatin structure during transcription by preventing histone exchange
por: Smolle, Michaela, et al.
Publicado: (2012)